PHILADELPHIA, PA – March 28 2008 – Bio-Rad Laboratories, Inc. (AMEX: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostic products, announced today the release of seven new high-quality infrared databases including:
Name of Database Number of Spectra
Pharmaceutical Excipients 882
Pollutants (IR Vapor Phase) 910
Flavors & Fragrances (IR Vapor Phase) 496
Protective Materials 772
Acrylates & Methacrylates 478
Steroids, Androgens, Progestins, & Estrogens 305
Bio-Rad’s spectral databases, which include the highly regarded Sadtler collections, are used by scientists worldwide in the verification, classification, and identification of chemical substances across multiple areas of research. Applications include pharmaceutical, forensic, environmental, materials sciences, polymers, and many others. With the addition of these databases, Bio-Rad now offers over 100 infrared spectral databases. For complete details on each new database (including indices), please go to: http://www.knowitall.com/databases
“When it comes to infrared, Bio-Rad provides the widest range of software and databases, so users can choose solutions that make the most sense for the way they work,” said Marie Scandone, Database Product Manager, Bio-Rad Informatics, “By providing our customers even more application choices with the addition of these new databases, Bio-Rad continues its commitment to offer high-quality spectral data collections that address the needs of the research community.”
Bio-Rad’s Sadtler Database Solutions for Spectroscopy have become industry standards in both commercial and academic laboratories worldwide, offering a unique blend of spectral data and state-of-the-art database building, management, search, analysis, prediction, and reporting tools. The spectral collection contains over 1.3 million spectra and includes IR, NMR, MS, Raman, NIR, UV-Vis data covering pure compounds and a broad range of commercial compounds.
Bio-Rad’s Informatics Division Bio-Rad’s Informatics Division (www.informatics.bio-rad.com) specializes in state-of-the-art software and database solutions for the scientific community. Bio-Rad is the leading publisher of fully verified spectral databases with a collection of over 1.3 million spectra. The company’s award-winning KnowItAll Informatics System offers a fully integrated environment with flexible and expandable software and database solutions for spectroscopy (IR, NMR, MS, Raman, NIR, UV-Vis, and spectral data management), cheminformatics, chemometrics, metabolomics, and in silico ADME/Tox prediction.
About Bio-Rad Bio-Rad Laboratories, Inc. (AMEX: BIO and BIOb) has remained at the center of scientific discovery for more than 50 years manufacturing and distributing a broad range of products for the life science research and clinical diagnostic markets. The company is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. Founded in 1952, Bio-Rad is headquartered in Hercules, California, and serves more than 85,000 research and industry customers worldwide through its global network of operations. The company employs approximately 6,300 people globally and had revenues approaching $1.5 billion in 2007. For more information, visit http://www.bio-rad.com
This release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements generally can be identified by the use of forward-looking terminology such as, “believe,” “expect,” “may,” “will,” “intend,” “estimate,” “continue,” or similar expressions or the negative of those terms or expressions. Such statements involve risks and uncertainties, which could cause actual results to vary materially from those expressed in or indicated by the forward-looking statements. For further information regarding the Company’s risks and uncertainties, please refer to the “Risk Factors” in the Company’s public reports filed with the Securities and Exchange Commission, including the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006, as updated by subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The Company cautions you not to place undue reliance on forward-looking statements, which reflect an analysis only and speak only as of the date hereof. Bio-Rad Laboratories, Inc. disclaims any obligation to update these forward-looking statements.